Status:
COMPLETED
COVID-19 and Intestinal Microbiota in Children
Lead Sponsor:
Saint-Joseph University
Collaborating Sponsors:
Université Paris Cité
Conditions:
SARS-CoV2 Infection, COVID-19, Gut Microbiota, Mucosal Response, Children
Eligibility:
All Genders
1-12 years
Brief Summary
SARS-CoV-2 is the causative agent of the COVID-19 pandemic. It appears to cause only mild to moderate upper respiratory symptoms in children, in addition to gastrointestinal symptoms resulting from it...
Eligibility Criteria
Inclusion
- Within age limits
- positive PCR
Exclusion
- metabolic disorders, hepatic disorders, immunodeficiency, allergy, autoimmune diseases, IBD, food intolerance, antibiotic administration within 3 months, pro and prebiotic administration within 3 months
Key Trial Info
Start Date :
April 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 25 2023
Estimated Enrollment :
86 Patients enrolled
Trial Details
Trial ID
NCT06503887
Start Date
April 1 2022
End Date
September 25 2023
Last Update
July 16 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Saint Joseph university
Beirut, Lebanon